首页 › 基金 › Velan Capital Investment Management LP › ANTX
Velan Capital Investment Management LP 对 ANTX 的持仓历史
AN2 THERAPEUTICS INC · 医疗保健
Velan Capital Investment Management LP 在 Q3 2026 的 13F 申报中披露持有 ANTX(AN2 THERAPEUTICS INC)40,000 股,市值约 US$213K,约占其申报组合的 0.20%,在其申报持仓中市值排名第 31 位。 Velan Capital Investment Management LP 最近 2 个申报季度中有 2 个季度披露了 ANTX 持仓,最早可追溯至 Q2 2026。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
Velan Capital Investment Management LP 对 ANTX 的持仓演变
Velan Capital Investment Management LP 于 Q2 2026 首次披露 ANTX 持仓:40,000 股(约 US$194K)。 该持仓在 Q3 2026 达到峰值 40,000 股,市值约 US$213K。 在 2 次申报中,Velan Capital Investment Management LP 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 40,000 股、市值约 US$213K。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2026 | 40.00K | $193.60K | 新进 |
| Q3 2026 | 40.00K | $212.80K | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 ANTX 与 13F 数据
ANTX(AN2 THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 47 只申报持有 ANTX,申报仓位最大的包括:Vivo Capital, LLC (US$16.8M), Commodore Capital LP (US$14.2M), Spruce Street Capital LP (US$9.3M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ANTX 的基金
- Vivo Capital, LLC 3.15M 股 · $16.78M · Q3 2026
- Commodore Capital LP 2.93M 股 · $14.20M · Q2 2026
- Spruce Street Capital LP 1.75M 股 · $9.32M · Q3 2026
- Almitas Capital LLC 1.47M 股 · $7.11M · Q2 2026
- ACORN CAPITAL ADVISORS, LLC 1.30M 股 · $6.92M · Q3 2026
- Boxer Capital Management, LLC 749.03K 股 · $3.63M · Q2 2026
- Tetragon Partners GP Ltd 603.42K 股 · $3.21M · Q3 2026
- Sio Capital Management, LLC 548.10K 股 · $2.92M · Q3 2026
- Ally Bridge Group (NY) LLC 526.32K 股 · $2.55M · Q2 2026
- Aldebaran Capital, LLC 367.71K 股 · $1.96M · Q3 2026
- Prosight Management, LP 350.88K 股 · $1.87M · Q3 2026
- Stonepine Capital Management, LLC 350.88K 股 · $1.87M · Q3 2026
更多关于 Velan Capital Investment Management LP
常见问题
How long has Velan Capital Investment Management LP held ANTX?
Velan Capital Investment Management LP has disclosed ANTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Velan Capital Investment Management LP's current position in ANTX?
As of Q3 2026, Velan Capital Investment Management LP holds 40.00K shares of ANTX (AN2 THERAPEUTICS INC), valued at $212.80K, representing 0.20% of its reported portfolio and ranking #31.
Has Velan Capital Investment Management LP been buying or selling ANTX?
In the latest 13F filing (Q3 2026), Velan Capital Investment Management LP held unchanged its position in ANTX. The position peaked in Q3 2026 at 40.00K shares.
Which other funds hold ANTX?
Other major institutional holders of ANTX include Vivo Capital, LLC, Commodore Capital LP, Spruce Street Capital LP, among 47 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.